The deadline has been extended for UAMS employees to submit innovative therapeutic or drug discovery ideas to the AR Health Ventures Accelerator (ARHVA) for significant financial and administrative support toward commercialization. 

Selected projects receive financial grants of up to $50,000 project management, budget allocation and progress tracking. 

All UAMS employees are eligible to apply, including trainees and postdoctoral fellows. 

The full Request for Applications document outlining the application process is available on the BioVentures website, as is a detailed FAQ. Applications are due Oct. 31. 

For more information, contact BioVentures Senior Program Manager Stefanie Kennon-McGill, Ph.D., at skennonmcgill@uams.edu.